To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

OPIOID DRUGS

TODAY'S HEADLINES

FDA requires warning on opioids

FDA is requiring a new boxed warning on immediate-release opioids and several other new safety labeling changes. Read more

Walgreens, OptumRx form pharmacy partnership

Find out what the new partnership between Walgreens Boots Alliance and OptumRx may mean. Read more

CONTINUING PHARMACY EDUCATION

Part 2: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose

This month's CE activity is open for pharmacists and pharmacy technicians. "Part II: Law: Educating and empowering patients and caregivers: The pharmacist's role in reducing the risk of opioid overdose." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

CDC issues opioid prescribing guidelines

The Centers for Disease Control and Prevention (CDC) issued new voluntary guidelines for prescribing opioid medications for chronic pain, excluding cancer, palliative, and end-of-life care. Read more

March 25, 2016

Related Articles

FDA makes sweeping changes for opioids

Aetna, Humana may form huge PBM

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us